Clinical Trials Logo

Immune Checkpoint Inhibitor clinical trials

View clinical trials related to Immune Checkpoint Inhibitor.

Filter by:

NCT ID: NCT04419441 Recruiting - Hodgkin Lymphoma Clinical Trials

Immune Checkpoint Inhibitors and Radiotherapy in Relapsed/Refractory Hodgkin Lymphoma

ICI-RT-1
Start date: June 24, 2020
Phase:
Study type: Observational

This is an observational retrospective study to investigate the efficacy and safety of the treatment with an immune checkpoint inhibitor (nivolumab or pembrolizumab) in combination with radiotherapy in patients with relapsed/refractory classical Hodgkin lymphoma.

NCT ID: NCT04414969 Recruiting - Chemotherapy Effect Clinical Trials

Anti-PD-1 Antibody Combined With Peg-Asparaginase and Chidamide for the Early Stage of NK/T Cell Lymphoma

Start date: June 26, 2020
Phase: Phase 2
Study type: Interventional

This prospective pilot study to evaluate the efficacy and safety of the anti-PD-1 antibody combine with Peg-asparaginase and Chidamide regimen for stage IE and IIE ENKTL.